Abstract
Abstract
Background
Trypanosoma cruzi is the etiological agent of Chagas disease (CD) or American trypanosomiasis, an important public health problem in Latin America. Benznidazole (BZ), a drug available for its treatment, has limited efficacy and significant side effects. Essential oils (EOs) have demonstrated trypanocidal activity and may constitute a therapeutic alternative. Our aim was to evaluate the efficacy of the EOs of clove (CEO - Syzygium aromaticum) and ginger (GEO - Zingiber officinale), administered alone and in combination with BZ, in Swiss mice infected with T. cruzi.
Methods
The animals were inoculated with 10,000 blood trypomastigotes of the Y strain of T. cruzi II by gavage and divided into four groups (n = 12 to 15): 1) untreated control (NT); 2) treated with BZ; 3) treated with CEO or GEO; and 4) treated with BZ + CEO or GEO. The treatments consisted of oral administration of 100 mg/kg/day, from the 5th day after parasite inoculation, for 20 consecutive days. All groups were submitted to fresh blood examination (FBE), blood culture (BC), conventional PCR (cPCR) and real-time PCR (qPCR), before and after immunosuppression with cyclophosphamide.
Results
Clove and ginger EOs, administered alone and in combination with BZ, promoted suppression of parasitemia (p < 0.0001), except for the animals treated with CEO alone, which presented a parasitemia curve similar to NT animals. However, there was a decrease in the BC positivity rate (p < 0.05) and parasite load (< 0.0001) in this group. Treatment with GEO alone, on the other hand, besides promoting a decrease in the BC positivity rate (p < 0.05) and parasite load (p < 0.01), this EO also resulted in a decrease in mortality rate (p < 0.05) of treated mice.
Conclusions
Decreased parasite load, as detected by qPCR, was observed in all treatment groups (BZ, CEO, GEO and BZ + EOs), demonstrating benefits even in the absence of parasitological cure, thus opening perspectives for further studies.
Publisher
Springer Science and Business Media LLC
Subject
Complementary and alternative medicine
Reference39 articles.
1. Chagas C. Nova tripanozomiaze humana: estudos sobre a morfolojia e o ciclo evolutivo do Schizotrypanum cruzi n. gen., n. sp., ajente etiolojico de nova entidade morbida do homem. Mem Inst Oswaldo Cruz. 1909;1(2):159–218 https://doi.org/10.1590/S0074-02761909000200008.
2. World Health Organization. Chagas disease (American trypanosomiasis). Available from: https://www.who.int/health-topics/chagas-disease#tab=tab_1.
3. Brasil MS. Doença de Chagas Aguda e distribuição espacial dos triatomíneos de importância epidemiológica, Brasil 2012 a 2016. Bol Epidemiol. 2019;50:10 https://www.saude.gov.br/images/pdf/2019/janeiro/23/2018-025.pdf.
4. Rassi A, Rassi A, Rezende JM. American Trypanosomiasis (Chagas disease). Infect Dis Clin N Am. 2012;26(2):275–91 https://doi.org/10.1016/j.idc.2012.03.002.
5. Pedrosa RC, Bem AF, Locatelli C, Pedrosa RC, Geremias R, Filho DW. Time-dependent oxidative stress caused by benznidazole. Redox Rep. 2001;6:265–70.
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献